Search Results

SU14813 double bond Z 50mg 50mg  | Purity Not Available

Adooq Bioscience

SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3).

More Information Supplier Page

SU14813 double bond Z 5mg 5mg  | Purity Not Available

Adooq Bioscience

SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3).

More Information Supplier Page

SU14813 double bond Z 25mg 25mg  | Purity Not Available

Adooq Bioscience

SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3).

More Information Supplier Page